Transcatheter aortic valve replacement in elderly patients.

Area of Science:

• Cardiovascular Medicine
• Interventional Cardiology
• Geriatric Cardiology

Background:

• Aortic stenosis is the most prevalent native valve disease in the elderly, impacting up to 5% of this demographic.
• Surgical aortic valve replacement is the standard treatment for severe symptomatic aortic stenosis, but carries increased risks in elderly patients with comorbidities.
• Transcatheter aortic valve replacement (TAVR) provides a less invasive therapeutic option for high-risk surgical patients.

Purpose of the Study:

• To review the background and clinical applications of TAVR in elderly patients.
• To highlight TAVR as a therapeutic alternative for severe aortic stenosis in older adults.
• To discuss the safety and efficacy of TAVR in this patient population.

Main Methods:

• Review of multicenter registries and randomized trials evaluating TAVR.
• Analysis of clinical data on TAVR outcomes in elderly patients.
• Synthesis of evidence regarding TAVR's safety and efficacy.

Main Results:

• Multicenter registries and a randomized trial have confirmed the safety and efficacy of TAVR.
• TAVR offers a viable treatment option for elderly patients with severe aortic stenosis who are at high surgical risk.
• The procedure avoids open-heart surgery and cardiopulmonary bypass.

Conclusions:

• TAVR is a safe and effective treatment for severe aortic stenosis in elderly patients, particularly those with high surgical risk.
• The minimally invasive nature of TAVR makes it a crucial advancement in managing valvular heart disease in older adults.
• Clinical evidence supports TAVR as a definitive therapy option, reducing symptoms and improving survival.